Clinical Trial: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: The Assessment of Prednisone In Remission Trial (TAPIR) - Centers of Excellence Approach

Brief Summary: This study is a multi-center randomized controlled trial to evaluate the effects of using low-dose prednisone as compared to stopping prednisone treatment entirely. Participants will be randomized 1:1 to taper their prednisone dose down to 5 mg/day or to 0 mg/day for the duration of the study (approximately six months) or until a study endpoint.